Literature DB >> 21460736

A treatment strategy for complex cases of osteomyelitis in children and its applicability on three exemplary cases.

Sebastian F Baumbach1, Lukas Hobohm, Gerald E Wozasek.   

Abstract

The aim of this study was to carry out a two-step surgical approach for complex cases of pediatric osteomyelitis. The surgical technique used here involved initial bone debridement and stabilization by a customized spacer (intramedullary Kirschner wires mantled with refobacin-palacosa cement). After infection eradication, the spacer was removed and distraction osteogenesis performed. This study included one boy and two girls (aged 7-10 years) with severe osteomyelitis (tibia: two, femur: one). At least 50% of the bone was initially resected, and either a bifocal physeal distraction (tibia) or callus distraction (subtrochanteric osteotomy) was performed. At discharge they were able to walk without assistance. Complete infection eradication and load restraining reconstruction was achieved in all three children.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21460736     DOI: 10.1097/BPB.0b013e3283458846

Source DB:  PubMed          Journal:  J Pediatr Orthop B        ISSN: 1060-152X            Impact factor:   1.041


  3 in total

1.  [Acute haematogenous osteomyelitis in children : Diagnostic algorithm and treatment strategies].

Authors:  M Willegger; A Kolb; R Windhager; C Chiari
Journal:  Orthopade       Date:  2017-06       Impact factor: 1.087

2.  Bone transport in the management of post-osteomyelitis femoral defects in children: A case series with a minimum of 10-year follow-up in Uganda.

Authors:  Antonio Loro; Francesca Loro; Fulvio Franceschi; Niall Brown
Journal:  J Child Orthop       Date:  2022-08-02       Impact factor: 1.917

Review 3.  Recommendations for the treatment of osteomyelitis.

Authors:  Ana Lucia L Lima; Priscila R Oliveira; Vladimir C Carvalho; Sergio Cimerman; Eduardo Savio
Journal:  Braz J Infect Dis       Date:  2014-04-01       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.